These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3887536)

  • 21. [1st research on the treatment of climacteric with a new drug (controlled clinical study)].
    Cazzola D; Confalonieri A; Lucchese V
    Minerva Ginecol; 1974 Mar; 24(5):250-64. PubMed ID: 4603971
    [No Abstract]   [Full Text] [Related]  

  • 22. [Evaluation of hormone replacement therapy in the perimenopause by means of Menopause Rating Scale (MRS I)].
    Hauser GA; Ernst U
    Zentralbl Gynakol; 1999; 121(11):530-6. PubMed ID: 10612221
    [No Abstract]   [Full Text] [Related]  

  • 23. Transdermal dosage forms.
    Shaw JE
    Methods Enzymol; 1985; 112():448-61. PubMed ID: 3930919
    [No Abstract]   [Full Text] [Related]  

  • 24. [Systen--transdermal estradiol for substitution following surgical menopause].
    Rachev E; Karag'ozov I
    Akush Ginekol (Sofiia); 1995; 34(3):74-6. PubMed ID: 8743861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Estradiol valerianate in the treatment of female climacteric].
    Pĕrez de Salazar JL; Garcĭa Torres FZ; Ruiz Velasco V; Conde Manjarrez BI
    Ginecol Obstet Mex; 1971 Nov; 30(181):527-37. PubMed ID: 5131135
    [No Abstract]   [Full Text] [Related]  

  • 26. [Topical hormonal treatment and urogenital atrophy].
    Sitruk-Ware R; Thomas JL
    Praxis (Bern 1994); 1997 Aug; 86(33):1245-8. PubMed ID: 9381009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparison of transdermal with oral hormone substitution: a multicenter study with a new matrix patch].
    Sajtos B; Herold J; Winkler UH; Schindler AE
    Zentralbl Gynakol; 1995; 117(10):524-30. PubMed ID: 7491835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical effects of 17 beta-estradiol and norethisterone acetate in postmenopausal Thai women.
    Limpaphayom KK; Bunyavejchevin S
    J Med Assoc Thai; 2000 Apr; 83(4):407-16. PubMed ID: 10808701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Estrogen substitution using a transdermal system].
    Schenkel L; Barlier D; Gay C; Gschwind T
    Rev Fr Gynecol Obstet; 1988 Jun; 83(6):453-8. PubMed ID: 3043634
    [No Abstract]   [Full Text] [Related]  

  • 30. Does adding estrogen to the hormone-free days of an oral contraceptive (OC) cycle reduce menopausal symptoms in perimenopausal OC users?
    Bielanski TE
    J Fam Pract; 2001 Oct; 50(10):838. PubMed ID: 11674879
    [No Abstract]   [Full Text] [Related]  

  • 31. Efficacy, safety and acceptability of a seven-day, transdermal estradiol patch for estrogen replacement therapy.
    Jarupanich T; Lamlertkittikul S; Chandeying V
    J Med Assoc Thai; 2003 Sep; 86(9):836-45. PubMed ID: 14649968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of isopropanolic black cohosh extract for climacteric symptoms.
    Osmers R; Friede M; Liske E; Schnitker J; Freudenstein J; Henneicke-von Zepelin HH
    Obstet Gynecol; 2005 May; 105(5 Pt 1):1074-83. PubMed ID: 15863547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Continuous, low dosage estradiol administration with a vaginal ring: a placebo-controlled study].
    Casper F; Petri E; Benninghoff B
    Zentralbl Gynakol; 1998; 120(9):449-53. PubMed ID: 9796090
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topical sodium cromoglycate in management of chronic non-infectious conjunctivitis: a double blind controlled clinical trial.
    Vajpayee RB; Gupta SK; Angra SK
    Indian J Ophthalmol; 1985; 33(5):285-8. PubMed ID: 3939626
    [No Abstract]   [Full Text] [Related]  

  • 35. Topical heparin for recurrent genital herpes simplex virus infections. A proposed model for subsequent therapeutic trials.
    Grossman JH; Thonnard-Neumann E
    J Reprod Med; 1985 Sep; 30(9):675-6. PubMed ID: 3903156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patch up the menopause.
    Lancet; 1988 Apr; 1(8590):861-2. PubMed ID: 2895367
    [No Abstract]   [Full Text] [Related]  

  • 37. Transdermal estradiol gel 0.1% for the treatment of vasomotor symptoms in postmenopausal women.
    Hedrick RE; Ackerman RT; Koltun WD; Halvorsen MB; Lambrecht LJ
    Menopause; 2009; 16(1):132-40. PubMed ID: 18971794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Subdermal implantation of estradiol 17 beta (25 mg) in hysterectomized and ovariectomized women. Effects of increased serum estradiol level and neurovegetative climacteric complaints].
    Tsvetkov Ts; Tsvetkov K; Petkova U
    Akush Ginekol (Sofiia); 2001; 41 Suppl 4():11-2. PubMed ID: 11519312
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects on haemostasis of hormone replacement therapy with transdermal estradiol and oral sequential medroxyprogesterone acetate: a 1-year, double-blind, placebo-controlled study. The Writing Group for the Estradiol Clotting Factors Study.
    Thromb Haemost; 1996 Mar; 75(3):476-80. PubMed ID: 8701411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hormone treatment in menopause].
    Schindler AE
    MMW Munch Med Wochenschr; 1980 Jun; 122(26):967-9. PubMed ID: 6775194
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.